Recombinant adenovirus-p53 enhances the therapeutic effect of surgery and chemoradiotherapy combination in hypopharyngeal squamous cell carcinomas patients

The purpose of our study was to assess the safety and efficacy of recombinant adenovirus-p53 (rAd-p53) combined with surgery and chemoradiotherapy (CRT) for patients with hypopharyngeal squamous cell carcinomas (HPSCC). This study retrospectively and consecutively collected clinical data of 102 pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jun, Lv, Dan, Wang, Haiyang, Zou, Jian, Chen, Fei, Yang, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6393013/
https://www.ncbi.nlm.nih.gov/pubmed/30170471
http://dx.doi.org/10.1097/MD.0000000000012193

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6393013/
https://www.ncbi.nlm.nih.gov/pubmed/30170471
http://dx.doi.org/10.1097/MD.0000000000012193

Ejemplares similares